Indian J Pharm Close
 

Figure 2: Flow cytometric analysis of MCF-7 cells treated with CVLME. Cell cycle phase distribution of Sub-G1, G1, S and G2/M phases of control MCF-7 cells (a) and treated MCF-7 cells with the indicated doses of CVL (b-f) ME for 48 h

Figure 2: Flow cytometric analysis of MCF-7 cells treated with CVLME. Cell cycle phase distribution of Sub-G1, G1, S and G2/M phases of control MCF-7 cells (a) and treated MCF-7 cells with the indicated doses of CVL (b-f) ME for 48 h